The Delhi health scam investigation has widened after Haryana Police registered a murder case against Rajiv Rangeela over the suspicious death of Gyan Chand, a guard who was allegedly made a director of a company used to secure government supply contracts. The case is linked to the alleged ₹842-crore medical equipment and medicine procurement scam being investigated by Delhi Police’s Anti-Corruption Branch (ACB).
According to the report, Rangeela allegedly used Gyan Chand’s name and identity documents to create a company without the guard’s knowledge. The company was used to obtain a tender for supplying bedsheets and other linen materials to hospitals. Investigators allege that supplies worth about ₹25 crore were made under the arrangement, while departmental payments of around ₹75 crore were secured through alleged collusion.
The company’s operations and its connection with government tenders are now part of the investigation. The report states that Gyan Chand, who had worked for about 20 years as a watchman and tractor driver at Rangeela’s farmhouse in Karnal, had no actual role in the company’s business or in the tender process. It also states that he was allegedly unaware that he had been made a company director.
Gyan Chand died in suspicious circumstances at Rangeela’s farmhouse on 1 September, after the medical procurement investigation had begun. Haryana Police registered an FIR at Karnal’s Sadar police station following a complaint by Gyan Chand’s son. The investigation is examining allegations that he was killed and the death presented as suicide, or that he was compelled to take his own life. These are allegations under investigation and have not been established by a court.
The death case was also raised in court on 4 November during proceedings opposing Rangeela’s bail plea, according to information cited from the Delhi health department. The allegation presented in the proceedings was that Rangeela had misused Gyan Chand’s identity documents to make him a company director. The Haryana Police is investigating the death, while the Delhi ACB has also begun collecting information relevant to the case.
The wider procurement investigation concerns alleged payments of approximately ₹839 crore to five major companies linked to Rangeela. The total value of the alleged medical procurement scam is reported to be around ₹842 crore. The ACB is examining company directors, bank accounts, tender documents and electronic evidence to determine how the contracts and payments were processed.
The case puts the functioning of public hospital procurement under scrutiny because the allegations involve company ownership, tender access, supply billing and departmental payments. The investigation will need to establish Gyan Chand’s actual role, how his documents were obtained and used, whether the supplies were delivered as billed, and the responsibility of officials or private entities involved in approving the transactions. The police investigations and related court proceedings remain ongoing.
